about
Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretionsMucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of miceThe nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice.Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranesA recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strainImmunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar TyphimuriumA murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection.Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumorThe importance of mucosal immunity in defense against epithelial cancers.High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools.Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients.Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid feverComplementary DNA cloning of complement C8 beta and its sequence homology to C9.Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancerIntravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in miceIntravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells.Monitoring of vaccine-specific gamma interferon induction in genital mucosa of mice by real-time reverse transcription-PCR.Immunotherapeutic strategies for bladder cancer.Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion.Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines.Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.Vaccination route matters for mucosal tumors.Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder.Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumorsOrigin of segmental identity in the development of the leech nervous systemAn axial domain of HOM/Hox gene expression is formed by morphogenetic alignment of independently specified cell lineages in the leech HelobdellaA novel mucosal orthotopic murine model of human papillomavirus-associated genital cancersInduction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated miceRestoration of connexin 40 (Cx40) in Renin-producing cells reduces the hypertension of Cx40 null mice
P50
Q33784891-05849AE3-A498-4ABC-962B-D3EBCFCE0EB9Q33823755-36E2D874-513C-4486-B009-84968230A903Q33877406-2415D969-2FE9-49B8-A66B-34A17296D371Q34353473-387B9159-D160-448D-AE73-86CBBB82FCC1Q35273321-036F8401-2C70-4A11-96DC-D9DF018BAE79Q35434055-04CE50FE-E84E-4CC1-A10E-CBE15448AC17Q35532132-1F8593E4-2DEF-4214-B3C2-58B11AA5B7C7Q35550509-67EFC2BF-4548-4F13-B882-6DDE762A2E7AQ35599310-D3C71BB4-EA54-4AE9-A44E-4476B610FF7BQ35798992-772F7696-7843-4631-9DF2-B46153BBC408Q36070708-833D3C50-3C27-454D-A218-8A662F072FDBQ36110300-09E2A75A-D06D-4842-AA4E-1D48A4E903C9Q36194843-77829018-14CC-47B1-B7AD-C2EFC6543ABEQ36313476-1E5DB57A-4D94-463B-A0FB-7A41C1524553Q36471006-4C8CC114-032D-4FBC-8E8F-A2177C0CA6A7Q36593956-7B491902-7A3E-4A84-B902-B633AC6B0D9BQ36612204-F09AF7CA-BDF5-4BDE-B882-FF88148BB203Q36643691-6031FAEF-C2E7-4B53-AD65-43C8B0B71FC7Q36672549-67D35050-2E94-4FA2-AD6A-3489CE508740Q36977628-15D77FF5-18E9-49C1-AA40-9E916AAC9F0AQ37046514-4DAA9395-1CBA-4C11-BD7C-E29E1119705DQ37134623-C5D62328-FE1D-417E-9C87-CACB8FDA77CCQ37291438-93E0FD58-9D8D-45D2-9026-825C44D28794Q37596462-14F55BC9-8DBA-4C77-8672-AEC92B5E0DBDQ37712799-0AE4463C-DB81-4C16-9B96-3658931E5476Q43839571-BED3FAC0-49C1-4B78-A9F8-22C500324EFDQ44027001-7D639992-4C13-4BFA-AC90-83B5F829B2FDQ45402169-594C01A4-5B1B-4494-8858-7C5C5C4A7E88Q51495627-B57E723E-6976-48F3-8CE7-86D8BF57893CQ51573498-48E117B3-DA5C-41A9-9B15-7BC2A6A418DCQ64065617-3D0DCAB8-204B-4816-8B00-4EA3147C9339Q67652645-FFA70528-86F5-4145-8F68-39996FCE1D57Q72714705-B024E2D3-6D96-4492-8846-3C3A9F073980Q84573368-246583B9-E854-4CBA-84BE-B183A389069AQ84685134-5F47BF35-53B5-4977-B86B-729EE2D88BD0Q87419955-88E6FEC7-A737-4CB3-AD88-4060E4642609
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Denise Nardelli-Haefliger
@ast
Denise Nardelli-Haefliger
@en
Denise Nardelli-Haefliger
@es
Denise Nardelli-Haefliger
@nl
Denise Nardelli-Haefliger
@sl
type
label
Denise Nardelli-Haefliger
@ast
Denise Nardelli-Haefliger
@en
Denise Nardelli-Haefliger
@es
Denise Nardelli-Haefliger
@nl
Denise Nardelli-Haefliger
@sl
prefLabel
Denise Nardelli-Haefliger
@ast
Denise Nardelli-Haefliger
@en
Denise Nardelli-Haefliger
@es
Denise Nardelli-Haefliger
@nl
Denise Nardelli-Haefliger
@sl
P106
P31
P496
0000-0003-1812-9905